variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
FBN1-R1170H,FBN1,"Reported to cause a ""subdiagnostic variant"" of Marfan syndrome as recorded by OMIM in ClinVar. This comes from Montgomery et al 1998 (PMID: 9837823) who report studying this in a single affected family. However, there aren't later publications confirming this variant as causal, at it is quite common. 1 in 500 are expected to carry this, while the Marfan syndrome affects only 1 in 5,000.",High,Uncertain,Pathogenic,0.002,Other,Dominant,Heterozygous,,,5,chr15,48779352,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
VWF-Y1584C,VWF,"This variant is associated with causing Type 1 von Willebrand disease in a dominant fashion. This hereditary defect in coagulation makes individuals more susceptible to bleeding. Not all carriers of the variant have the disease (incomplete penetrance); type O blood may also be a risk factor. A vWF antigen assay can confirm presence of the disease. Individuals are not usually treated with medication, but prophylactic measures are recommended before surgery and behavioral modification to avoid activities with a high risk of trauma (particularly head trauma) is recommended.",Moderate,Likely,Pathogenic,0.0023,Blood,Dominant,Heterozygous,12649144;17080221,rs1800386,4,chr12,6127833,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TGDS-A100S,TGDS,Ehmke et al 2014 (PMID: 25480037) report this variant causes Catel Manzke syndrome in a recessive manner. This effect is recorded in ClinVar by OMIM.,Moderate,Likely,Pathogenic,,Other,Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
FANCG-R513Q,FANCG,"Rare polymorphism. Hypothesized to increase susceptibility to childhood acute myeloid leukemia, but the numbers in the study failed to have statistical significance.",Low,Uncertain,Pathogenic,0.0072,Blood;Cancer,Dominant,Heterozygous,16643430,rs17885240,2,chr9,35075022,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TLR5-R392X,TLR5,"This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.",Low,Uncertain,Pathogenic,0.044,Immune system,Complex/Other,Heterozygous,14623910;16027372;17516623;18230059,rs5744168,1,chr1,223285200,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Homozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Homozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
OCA2-R419Q,OCA2,"This variant is associated with eye color, as is OCA2 R305W. Individuals with this variant are reported to be more likely to have green/hazel eyes as opposed to blue/gray eyes. Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.057,Hearing and vision;Skin,Unknown,Heterozygous,12163334,rs1800407,,chr15,28230318,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Homozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
RNASEH2B-I309Shift,RNASEH2B,"This variant is predicted to be highly disruptive. Although other disruptive variants in this gene are reported to cause Aicardi-Goutieres syndrome in a recessive manner (a rare, fatal childhood disease), those variants were upstream of this position, and this variant is too common to be consistent with causing that disease (2% allele frequency). Based on this, it is tentatively evaluated as benign.",Low,Uncertain,Benign,0.023,Heart and circulatory,Unknown,Heterozygous,16845400,,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
FLG-R3530S,FLG,"Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.",Low,Uncertain,Benign,0.11,Skin,Unknown,Heterozygous,,rs72697000,,chr1,152276772,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
DSPP-R68W,DSPP,"Probably benign. One report linked this to causing dentinogenesis Imperfecta type II in a large Swedish family, but subsequent publications have observed this is a common variant and conclude it is a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.14,"Mouth, liver, and digestive",Unknown,Heterozygous,14758537;17452557;18797159,rs36094464,,chr4,88533540,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
TXNDC3-I338T,TXNDC3,"Tentatively classified as benign, but predicted to be damaging and other variants in this gene are implicated in causing primary ciliary dyskinesia (situs inversus, chronic sinusitis, and bronchiectasis).",Low,Uncertain,Benign,0.038,Anatomical and congenital;Breathing,Unknown,Heterozygous,,rs62001870,,chr7,37923923,C,http://evidence.pgp-hms.org/genomes?display_genome_id=cc38e9ea068d20b85f2da9e74153eac010007774&access_token=23c6ba8e56904d7b83f9588b1c3b283e
